The Current Ratio as of November 2024 (TTM) for Vincerx Pharma, Inc. (VINC) is 2.17

According to Vincerx Pharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.17. This represents a change of -3.15% compared to the average of 2.24 of the last 4 quarters.

Vincerx Pharma, Inc. (VINC) Historical Current Ratio (quarterly & annually)

How has VINC Current Ratio performed in the past?

The mean historical Current Ratio of Vincerx Pharma, Inc. over the last ten years is 9.24. The current 2.17 Current Ratio has changed 2.24% with respect to the historical average. Over the past ten years (40 quarters), VINC's Current Ratio was at its highest in in the March 2020 quarter at 23.65. The Current Ratio was at its lowest in in the December 2019 quarter at 0.

Vincerx Pharma, Inc. (VINC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vincerx Pharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vincerx Pharma, Inc. (VINC) Average Current Ratio

How has VINC Current Ratio performed in the past?

The current Current Ratio of Vincerx Pharma, Inc. (VINC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vincerx Pharma, Inc. (VINC) Current Ratio vs. Peers

How is VINC’s Current Ratio compared to its peers?

Vincerx Pharma, Inc.’s Current Ratio is less than Spero Therapeutics, Inc. (2.68), less than Bolt Biotherapeutics, Inc. (3.16), greater than Coherus BioSciences, Inc. (1.25), less than Gracell Biotechnologies Inc. (7.73), less than Neoleukin Therapeutics, Inc. (15.33), greater than Applied Therapeutics, Inc. (1.06), less than Lyra Therapeutics, Inc. (3.64), less than Shattuck Labs, Inc. (7.96), less than BioAtla, Inc. (3.11), less than Monopar Therapeutics Inc. (5.41K), greater than Senti Biosciences, Inc. (1.92), less than Processa Pharmaceuticals, Inc. (3.97), less than Fresh Tracks Therapeutics, Inc. (6.98), less than LAVA Therapeutics N.V. (6.39), greater than TRACON Pharmaceuticals, Inc. (0.66), less than Rezolute, Inc. (13.79), less than XOMA Corporation (7.52), less than Sio Gene Therapies Inc. (5.52), less than Protara Therapeutics, Inc. (9.85), greater than Vaccinex, Inc. (0.77), less than Miromatrix Medical Inc. (3.46), less than Surrozen, Inc. (7.40),

Build a custom stock screener for Vincerx Pharma, Inc. (VINC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vincerx Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vincerx Pharma, Inc. (VINC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vincerx Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.